People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Manufacturing, Other Technology, Other, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tempur Sealy International, Inc. | — | Manufacturing | Growth/Late | $2.2B | $21.8B | 2025 |
| Zuora Inc | — | Other Technology | Series D+ | $221.0M | $3.6B | 2010 |
| Coupa Software Inc | — | Other | Series C | $99.5M | $1.4B | 2015 |
| Catapult Health, LLC | — | Healthtech | Series A | $27.7M | $52.2M | 2011 |
| Viverae, Inc. | — | Other Health Care | Series A | $8.4M | $30.3M | 2009 |
| O. Keller Holdings, Llc | — | Manufacturing | Seed | $1.5M | $19.0M | 2012 |
| EZ-Chow Inc. | — | Other Technology | Seed | $1.2M | $4.1M | 2021 |
| Creditbility, Inc. | — | Other | Pre-Seed | $1.0M | $4.7M | 2018 |
| Eagle Ford Royalty Partners Fund I, L.P. | — | Other | Pre-Seed | $500K | $11.6M | 2012 |
Scott Thompson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Thompson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian O'Malley | 1 | 18 |
| Neeraj Agrawal | 1 | 17 |
| Peter Fenton | 1 | 16 |
| Jason Pressman | 1 | 13 |
| Jeffrey Smith | 1 | 11 |
| David Tamburri | 1 | 10 |
| Charles Beeler | 1 | 9 |
| Michelangelo Volpi | 1 | 8 |
| MARK SHERMAN | 1 | 8 |
| Robert Reynolds | 1 | 7 |
| Jonathan Ebinger | 1 | 5 |
| David Stephens | 1 | 4 |
| Bryan Stolle | 1 | 4 |
| Shawn Price | 1 | 3 |
| Timothy Haley | 1 | 3 |
| Tien Tzuo | 1 | 2 |
| Gabriel Goncalves | 1 | 2 |
| David Michel | 1 | 2 |
| Craig Hanson | 1 | 2 |
| Michael Theilmann | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.